These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36449291)

  • 1. Effect of Patient Characteristics on Uptake of Screening Using a Mailed Human Papillomavirus Self-sampling Kit: A Secondary Analysis of a Randomized Clinical Trial.
    Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
    JAMA Netw Open; 2022 Nov; 5(11):e2244343. PubMed ID: 36449291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.
    Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
    JAMA Netw Open; 2019 Nov; 2(11):e1914729. PubMed ID: 31693128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening.
    Meenan RT; Troja C; Buist DSM; Tiro JA; Lin J; Anderson ML; Gao H; Green BB; Winer RL
    JAMA Netw Open; 2023 Mar; 6(3):e234052. PubMed ID: 36947040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial.
    Winer RL; Lin J; Anderson ML; Tiro JA; Green BB; Gao H; Meenan RT; Hansen K; Sparks A; Buist DSM
    JAMA; 2023 Nov; 330(20):1971-1981. PubMed ID: 38015219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does mailing unsolicited HPV self-sampling kits to women overdue for cervical cancer screening impact uptake of other preventive health services in a United States integrated delivery system?
    Kariya H; Buist DSM; Anderson ML; Lin J; Gao H; Ko LK; Winer RL
    Prev Med; 2022 Jan; 154():106896. PubMed ID: 34800474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a U.S. healthcare system: The STEP trial.
    Winer RL; Lin J; Anderson ML; Tiro JA; Meenan RT; Hansen K; Gao H; Sparks A; Greene DN; Kilgore-Martin S; Green BB; Buist DSM
    Contemp Clin Trials; 2022 Nov; 122():106960. PubMed ID: 36241145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial.
    Montealegre JR; Anderson ML; Hilsenbeck SG; Chiao EY; Cantor SB; Parker SL; Daheri M; Bulsara S; Escobar B; Deshmukh AA; Jibaja-Weiss ML; Zare M; Scheurer ME
    Trials; 2020 Oct; 21(1):872. PubMed ID: 33087164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.
    Winer RL; Tiro JA; Miglioretti DL; Thayer C; Beatty T; Lin J; Gao H; Kimbel K; Buist DSM
    Contemp Clin Trials; 2018 Jan; 64():77-87. PubMed ID: 29113956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial.
    Pretsch PK; Spees LP; Brewer NT; Hudgens MG; Sanusi B; Rohner E; Miller E; Jackson SL; Barclay L; Carter A; Wheeler SB; Smith JS
    Lancet Public Health; 2023 Jun; 8(6):e411-e421. PubMed ID: 37182529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits.
    Malone C; Tiro JA; Buist DS; Beatty T; Lin J; Kimbel K; Gao H; Thayer C; Miglioretti DL; Winer RL
    J Med Screen; 2020 Sep; 27(3):146-156. PubMed ID: 31744374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
    Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
    BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
    Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
    JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result.
    Tiro JA; Betts AC; Kimbel K; Buist DSM; Mao C; Gao H; Shulman L; Malone C; Beatty T; Lin J; Thayer C; Miglioretti DL; Winer RL
    J Womens Health (Larchmt); 2019 Mar; 28(3):384-392. PubMed ID: 30481121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial.
    Spees LP; Des Marais AC; Wheeler SB; Hudgens MG; Doughty S; Brewer NT; Smith JS
    Trials; 2019 Dec; 20(1):788. PubMed ID: 31881928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
    Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
    JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multilevel Primary Care Intervention to Improve Follow-Up of Overdue Abnormal Cancer Screening Test Results: A Cluster Randomized Clinical Trial.
    Atlas SJ; Tosteson ANA; Wright A; Orav EJ; Burdick TE; Zhao W; Hort SJ; Wint AJ; Smith RE; Chang FY; Aman DG; Thillaiyapillai M; Diamond CJ; Zhou L; Haas JS
    JAMA; 2023 Oct; 330(14):1348-1358. PubMed ID: 37815566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Home-Mailed Versus General Practitioner-Delivered Vaginal Self-Sampling Kit for Cervical Cancer Screening: A Cluster Randomized Controlled Trial with a Cost-Effectiveness Analysis.
    Boyard J; Caille A; Brunet-Houdard S; Sengchanh-Vidal S; Giraudeau B; Marret H; Rolland-Lozachmeur G; Rusch E; Gaudy-Graffin C; Haguenoer K
    J Womens Health (Larchmt); 2022 Oct; 31(10):1472-1480. PubMed ID: 35834620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.